AdvisorShares Alpha DNA Equity Sentiment ETF SENT 深 沪
已收盘 10-24 16:00:00 美东时间
21.2172
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 21.2172
- 总市值 1060.86万
- 52周最高 25.0709
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 21.1024
- 委 比 0.00%
- 总股本 50.00万
- 历史最高 29.19
- 量 比 0
- 振 幅 0.00%
- 历史最低 20.16
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Karyopharm Strengthens Balance Sheet With $100 Million Financing To Extend Cash Runway Into 2026
Karyopharm secures $100 million financing, extends cash runway into 2026, projects $42 million–$44 million Q3 revenue, and advances Phase 3 selinexor trial.
10-09 01:31
Get ready for the "BIGGEST SURPRISE" of 2025 from Gravity
SOMETHING BIG IS COMING! BANGKOK, Oct. 6, 2025 /PRNewswire/ -- Calling all gamers and Gravity fans — this is the moment you've been waiting for! Gravity is set to reveal the biggest surprise...
10-06 16:13
CON EDISON LEADERSHIP TO WEBCAST INVESTOR PRESENTATION ON OCTOBER 7
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Consolidated Edison, Inc. (NYSE: ED) will webcast an investor presentation, Delivering Reliable and Resilient Energy for the Future, from 8:30 a.m. to ...
10-02 04:30
Q3 Virtual Investor Summit: On-Demand Presentations Now Available
NEW YORK, NY / ACCESS Newswire / September 30, 2025 / Investor Summit Group is ...
10-01 01:00
U.S. Trade Representative Jamieson Greer Says AUGUST 1 TARIFF RATES REPRESENT TRUMP'S TARIFF STRUCTURE GOING FORWARD
- Economic Club Of New York Event
10-01 00:57
Karyopharm Completes Enrollment In Phase 3 Trial Testing New Combo Therapy For Myelofibrosis Patients
Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it has completed enrollment in the Phase 3 SENTRY trial, which is evaluating
09-10 19:02
AMGEN TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE
THOUSAND OAKS, Calif., Sept. 4, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 9:15 a.m. ET on September 9, 2025. Pet...
09-05 04:01
BRP PRESENTS ITS SECOND QUARTER RESULTS FOR FISCAL YEAR 2026
Highlights Revenues of $1,888.2 million, an increase of 4.3% compared to last year; Net income of $57.1 million, an increase of 36.0% compared to last year; Normalized EBITDA [1] of $213.2 m...
08-29 18:00
KEYCORP TO PRESENT AT THE BARCLAYS GLOBAL FINANCIAL SERVICES CONFERENCE
CLEVELAND, Aug. 26, 2025 /PRNewswire/ -- KeyCorp (NYSE: KEY) announced today that Randy Paine, Head of Institutional Banking, and Clark Khayat, Chief Financial Officer, will present at the B...
08-26 20:30
Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) rose sharply in pre-market...
08-20 19:24
